Craneware (LON:CRW) Receives “Buy” Rating from Berenberg Bank

Craneware (LON:CRW)‘s stock had its “buy” rating restated by equities research analysts at Berenberg Bank in a research note issued on Tuesday,Digital Look reports. They presently have a GBX 2,800 ($36.25) target price on the stock. Berenberg Bank’s price target would suggest a potential upside of 57.30% from the stock’s current price.

Separately, Shore Capital reissued a “buy” rating on shares of Craneware in a research report on Tuesday.

Craneware Stock Up 0.6 %

Shares of LON:CRW traded up GBX 10 ($0.13) during trading on Tuesday, hitting GBX 1,780 ($23.05). 37,042 shares of the company were exchanged, compared to its average volume of 85,129. The firm’s 50 day moving average price is GBX 1,967.43 and its 200-day moving average price is GBX 2,090.19. Craneware has a 12-month low of GBX 1,670 ($21.62) and a 12-month high of GBX 2,509.20 ($32.49). The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00. The stock has a market capitalization of £764.80 million, a P/E ratio of 65.76 and a beta of 0.28.

Craneware Company Profile

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group’s Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.